1. Home
  2. YJ vs RNAZ Comparison

YJ vs RNAZ Comparison

Compare YJ & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yunji Inc. American Depository Shares

YJ

Yunji Inc. American Depository Shares

HOLD

Current Price

$1.50

Market Cap

7.4M

ML Signal

HOLD

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

N/A

Current Price

$8.57

Market Cap

8.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YJ
RNAZ
Founded
2015
2016
Country
China
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4M
8.5M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
YJ
RNAZ
Price
$1.50
$8.57
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$280.00
AVG Volume (30 Days)
4.0K
9.6K
Earning Date
11-25-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$47,760,127.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.37
$6.15
52 Week High
$2.67
$468.44

Technical Indicators

Market Signals
Indicator
YJ
RNAZ
Relative Strength Index (RSI) 33.44 37.41
Support Level $1.51 $8.20
Resistance Level $1.65 $9.41
Average True Range (ATR) 0.05 0.45
MACD -0.00 0.07
Stochastic Oscillator 22.25 31.67

Price Performance

Historical Comparison
YJ
RNAZ

About YJ Yunji Inc. American Depository Shares

Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in the PRC.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

Share on Social Networks: